Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta-analysis and critical analysis.

Although tailored therapy performed better than empiric treatment, the lack of optimization of therapies failed to reliably achieve high cure rates (>90%). These results emphasize that H. pylori infection, like other infectious diseases, should utilize the principles of antimicrobial stewardship in relation to treatment guidance.